Alector, Inc. (ALEC) Financials

ALEC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 621.8 million 487.7 million
2023-09-30 672.4 million 509.8 million
2023-06-30 708.7 million 512.4 million
2023-03-31 748.3 million 565.3 million

ALEC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -46.3 million 11.5 million
2023-09-30 -46.4 million 10.1 million
2023-06-30 -44.2 million 10.2 million
2023-03-31 -49.6 million 11.0 million

ALEC Net Income

No data available :(

ALEC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 548.9 million - 38.9 million
2023-09-30 588.9 million - 40.2 million
2023-06-30 630.0 million - 40.9 million
2023-03-31 669.3 million - 42.2 million

ALEC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 83.7 million
2023-09-30 83.9 million
2023-06-30 83.6 million
2023-03-31 83.1 million

ALEC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 233000 47.7 million 14.9 million -
2023-09-30 94000 46.3 million 13.4 million -
2023-06-30 1.2 million 46.2 million 13.6 million -
2023-03-31 1.0 million 51.9 million 14.8 million -

ALEC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 15.2 million 6.6 million
2023-09-30 9.1 million 2.3 million
2023-06-30 56.2 million 2.2 million
2023-03-31 16.5 million 2.1 million

ALEC

Price: $5.39

52 week price:
3.66
9.07

Earnings Per Share: -1.56 USD

P/E Ratio: -3.41

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 209662

Market Capitalization: 519.5 million

Links: